Cystatin C: A marker of renal function or something more?

被引：58

作者：

Curhan, G ^{[1
]}

机构：

[1] Brigham & Womens Hosp, Boston, MA 02115 USA

来源：

CLINICAL CHEMISTRY | 2005年 / 51卷 / 02期

关键词：

D O I：

10.1373/clinchem.2004.044388

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：293 / 294

页数：2

共 21 条

[1] Plasma levels of cystatin-C and mannose binding protein are not associated with risk of developing systemic atherosclerosis [J].

Albert, MA ;

Rifai, N ;

Ridker, PM .

VASCULAR MEDICINE, 2001, 6 (03) :145-149

[2] Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death [J].

Apple, FS ;

Murakami, MM ;

Pearce, LA ;

Herzog, CA .

CLINICAL CHEMISTRY, 2004, 50 (12) :2279-2285

[3] Cardiac biomarkers in renal disease: The fog is slowly lifting [J].

Cameron, SJ ;

Green, GB .

CLINICAL CHEMISTRY, 2004, 50 (12) :2233-2235

[4] Increased cystatin C serum concentrations in patients with hepatic diseases of various severities [J].

Chu, SC ;

Wang, CP ;

Chang, YH ;

Hsieh, YS ;

Yang, SF ;

Su, JM ;

Yang, CC ;

Chiou, HL .

CLINICA CHIMICA ACTA, 2004, 341 (1-2) :133-138

[5] PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].

COCKCROFT, DW ;

GAULT, MH .

NEPHRON, 1976, 16 (01) :31-41

[6] K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification - Foreword [J].

Eknoyan, G ;

Levin, NW .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) :S14-S266

[7] Impact of thyroid dysfunction on serum cystatin C [J].

Fricker, M ;

Wiesli, P ;

Brändle, M ;

Schwegler, B ;

Schmid, C .

KIDNEY INTERNATIONAL, 2003, 63 (05) :1944-1947

[8] Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals [J].

Fried, L ;

Solomon, C ;

Shlipak, M ;

Seliger, S ;

Stehman-Breen, C ;

Bleyer, AJ ;

Chaves, P ;

Furberg, C ;

Kuller, L ;

Newman, A .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (12) :3184-3191

[9] Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization [J].

Go, AS ;

Chertow, GM ;

Fan, DJ ;

McCulloch, CE ;

Hsu, CY .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (13) :1296-1305

[10] Cystatin C, a novel risk marker for mortality in the general population: Data obtained from the PREVEND study [J].

Hillege, HL ;

Verhave, JC ;

Bakker, SJL ;

Gansevoort, RT ;

van Veldhuisen, DJ ;

de Jong, PE ;

de Zeeuw, D .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) :519A-519A

← 1 2 3 →